← Back to Search

Epileptic Patients for Traumatic Brain Injury (BCI Trial)

N/A
Waitlist Available
Led By Jeffrey G Ojemann, MD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Summary

We will observe epileptic patients who already have electrodes implanted on the brain and are receiving high-level brain stimulation for clinical purposes while testing their motor and language function. We propose to do a limited, low-level brain stimulation to show that the signatures of local activity in the target area change as an effect of brain stimulation. The goal of this study is to understand the feasibility of a novel recurrent brain-computer interface that could eventually promote targeted functional recovery in subjects who have had a brain injury.

Eligible Conditions
  • Traumatic Brain Injury
  • Epilepsy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Link EMG activity produced during a motor task to stimulation of a part of the brain
Secondary study objectives
Evaluate distribution of current from stimulation

Trial Design

1Treatment groups
Experimental Treatment
Group I: Epileptic PatientsExperimental Treatment1 Intervention
The population of patients with medically refractory epilepsy will already have been recommended clinically for electrode grid placement on the brain and high-level stimulation to map brain function.

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,791 Previous Clinical Trials
1,905,498 Total Patients Enrolled
Jeffrey G Ojemann, MDPrincipal InvestigatorUniversity of Washington
1 Previous Clinical Trials
20 Total Patients Enrolled
~1 spots leftby Sep 2025